Gambaran Umum
Pulmatrix, Inc., based in the United States, operates within the biotechnology sector focusing on the development of innovative inhaled therapies to address severe respiratory diseases using its patented iSPERSE technology. This technology enhances the delivery of drugs directly to the lungs by producing uniquely dense, small particles that are efficient in penetrating deep into the lung tissue. Pulmatrix's key project pipeline primarily targets conditions such as chronic obstructive pulmonary disease (COPD), asthma, and other respiratory ailments. The company is particularly noted for its innovative approach to respiratory care, aiming to improve patient outcomes and reduce systemic side effects by maximally utilizing localized delivery mechanisms. This strategic focus aligns with its broader mission to advance pulmonary disease treatment through breakthrough therapies.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Pulmatrix, Inc. per 2025 Jun 30 adalah 0.37 MM.
- Nilai operating income untuk Pulmatrix, Inc. per 2025 Jun 30 adalah -8.00 MM.
- Nilai net income untuk Pulmatrix, Inc. per 2025 Jun 30 adalah -7.93 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 0.37 | -8.00 | -7.93 |
2025-03-31 | 1.92 | -9.74 | -12.19 |
2024-12-31 | 7.81 | -7.14 | -9.56 |
2024-09-30 | 10.01 | -7.42 | -9.66 |
2024-06-30 | 11.39 | -8.70 | -10.84 |
2024-03-31 | 11.68 | -9.41 | -8.85 |
2023-12-31 | 7.30 | -14.74 | -14.12 |
2023-09-30 | 6.80 | -16.84 | -16.25 |
2023-06-30 | 6.92 | -18.00 | -17.53 |
2023-03-31 | 6.41 | -18.57 | -18.31 |
2022-12-31 | 6.07 | -18.95 | -18.84 |
2022-09-30 | 4.82 | -18.66 | -18.65 |
2022-06-30 | 4.02 | -18.18 | -21.78 |
2022-03-31 | 4.94 | -17.47 | -21.04 |
2021-12-31 | 5.17 | -16.59 | -20.17 |
2021-09-30 | 6.71 | -15.22 | -19.04 |
2021-06-30 | 10.02 | -11.88 | -21.41 |
2021-03-31 | 11.26 | -9.21 | -18.73 |
2020-12-31 | 12.63 | -9.86 | -19.31 |
2020-09-30 | 12.32 | -11.30 | -20.45 |
2020-06-30 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | -3.34 | -3.34 |
2024-12-31 | -2.62 | |
2024-09-30 | -2.64 | -2.64 |
2024-06-30 | -2.97 | -2.97 |
2024-03-31 | -2.42 | -2.42 |
2023-12-31 | -3.87 | |
2023-09-30 | -4.45 | -4.45 |
2023-06-30 | -4.86 | -4.86 |
2023-03-31 | -5.18 | -5.18 |
2022-12-31 | -5.46 | |
2022-09-30 | -6.71 | -6.71 |
2022-06-30 | -8.08 | -8.08 |
2022-03-31 | -8.20 | -8.20 |
2021-12-31 | -8.63 | |
2021-09-30 | -7.79 | -7.79 |
2021-06-30 | -9.91 | -9.91 |
2021-03-31 | -10.66 | -10.66 |
2020-12-31 | -13.43 | |
2020-09-30 | -16.49 | -16.49 |
2020-06-30 | -12.58 | -12.58 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Pulmatrix, Inc. per 2025 Jun 30 adalah -8.02 MM.
- Nilai cash from investing activities untuk Pulmatrix, Inc. per 2025 Jun 30 adalah 0.00 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -8.02 | 0.00 | |
2025-03-31 | -9.81 | -0.24 | |
2024-12-31 | -10.72 | -0.40 | |
2024-09-30 | -11.47 | -0.70 | 0.00 |
2024-06-30 | -12.55 | -1.02 | 0.00 |
2024-03-31 | -13.78 | -0.83 | 0.00 |
2023-12-31 | -15.98 | -0.68 | 0.05 |
2023-09-30 | -19.02 | -0.38 | 0.05 |
2023-06-30 | -18.48 | -0.07 | 1.44 |
2023-03-31 | -18.14 | -0.08 | 1.44 |
2022-12-31 | -19.36 | -0.09 | 1.23 |
2022-09-30 | -18.71 | -0.10 | 7.42 |
2022-06-30 | -18.41 | -0.20 | 6.04 |
2022-03-31 | -20.38 | -0.15 | 6.04 |
2021-12-31 | -19.73 | -0.14 | 43.48 |
2021-09-30 | -18.10 | -0.20 | 37.28 |
2021-06-30 | -20.30 | -0.20 | 50.15 |
2021-03-31 | -18.78 | -0.18 | 58.00 |
2020-12-31 | -12.48 | -0.28 | 20.98 |
2020-09-30 | -14.15 | -0.21 | 20.98 |
2020-06-30 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/libro untuk Pulmatrix, Inc. pada 2025 Jun 30 adalah 3.53.
- p/tbv untuk Pulmatrix, Inc. pada 2025 Jun 30 adalah 3.53.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | 3.53 | 3.53 | |
2025-03-31 | 2.94 | 2.94 | |
2024-12-31 | 2.29 | 2.29 | |
2024-09-30 | -0.72 | 0.59 | 0.59 |
2024-06-30 | -0.80 | 0.37 | 0.37 |
2024-03-31 | 0.30 | 0.30 | |
2023-12-31 | -0.42 | 0.34 | 0.34 |
2023-09-30 | -0.42 | 0.32 | 0.32 |
2023-06-30 | -0.54 | 0.37 | 0.37 |
2023-03-31 | -0.56 | 0.34 | |
2022-12-31 | 0.40 | 0.40 | |
2022-09-30 | 0.32 | 0.32 | |
2022-06-30 | 0.36 | 0.36 | |
2022-03-31 | -1.10 | 0.47 | 0.47 |
2021-12-31 | -1.28 | 0.54 | 0.59 |
2021-09-30 | -2.10 | 0.85 | 0.91 |
2021-06-30 | |||
2021-03-31 | -0.84 | 0.28 | 0.30 |
2020-12-31 | -10.47 | 8.74 | 10.34 |
2020-09-30 | -0.47 | 0.41 | 0.48 |
2020-06-30 | -0.54 | 0.52 | 0.70 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk Pulmatrix, Inc. pada 2025 Jun 30 adalah -0.70.
- EBIT (3 tahun) / EV untuk Pulmatrix, Inc. pada 2025 Jun 30 adalah -0.77.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -0.70 | -0.77 |
2025-03-31 | -0.57 | -0.73 |
2024-12-31 | -0.68 | -1.00 |
2024-09-30 | 2.38 | 3.34 |
2024-06-30 | 0.96 | 1.74 |
2024-03-31 | 1.06 | 1.20 |
2023-12-31 | 1.12 | 1.24 |
2023-09-30 | 0.95 | 1.10 |
2023-06-30 | 0.88 | 0.98 |
2023-03-31 | 0.75 | 0.78 |
2022-12-31 | 0.70 | 0.73 |
2022-09-30 | 0.71 | 0.66 |
2022-06-30 | 0.66 | 0.59 |
2022-03-31 | 0.66 | 0.64 |
2021-12-31 | 0.65 | 0.67 |
2021-09-30 | 1.80 | 1.76 |
2021-06-30 | ||
2021-03-31 | 0.39 | 0.41 |
2020-12-31 | -0.11 | -0.12 |
2020-09-30 | 0.82 | 0.83 |
2020-06-30 | 0.67 | 0.93 |
Efektivitas Manajemen
- roa untuk Pulmatrix, Inc. pada 2025 Jun 30 adalah -0.77.
- roe untuk Pulmatrix, Inc. pada 2025 Jun 30 adalah -0.92.
- roic untuk Pulmatrix, Inc. pada 2025 Jun 30 adalah -1.71.
- croic untuk Pulmatrix, Inc. pada 2025 Jun 30 adalah -1.41.
- ocroic untuk Pulmatrix, Inc. pada 2025 Jun 30 adalah -1.37.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.77 | -0.92 | -1.71 | -1.41 | -1.37 |
2025-03-31 | -0.31 | -0.50 | -1.07 | -1.24 | -1.20 |
2024-12-31 | -0.28 | -0.54 | -0.88 | -1.11 | -1.05 |
2024-09-30 | -0.29 | -0.55 | -0.50 | -0.63 | -0.58 |
2024-06-30 | -0.25 | -0.33 | -0.32 | -0.53 | -0.50 |
2024-03-31 | -0.40 | -0.52 | -0.57 | -0.68 | -0.67 |
2023-12-31 | -0.35 | -0.46 | -0.57 | -0.68 | -0.67 |
2023-09-30 | -0.35 | -0.46 | -0.74 | -0.72 | -0.78 |
2023-06-30 | -0.37 | -0.48 | -0.74 | -0.72 | -0.78 |
2023-03-31 | -0.35 | -0.44 | -0.66 | -0.60 | -0.65 |
2022-12-31 | -0.33 | -0.41 | -0.51 | -0.31 | -0.51 |
2022-09-30 | -0.39 | -0.48 | -0.51 | -0.31 | -0.51 |
2022-06-30 | -0.32 | -0.40 | -0.54 | -0.31 | -0.45 |
2022-03-31 | -0.29 | -0.36 | -0.47 | -0.32 | -0.46 |
2021-12-31 | -0.50 | -0.82 | -0.41 | 0.47 | -0.39 |
2021-09-30 | -0.44 | -0.91 | -0.41 | 0.41 | -0.37 |
2021-06-30 | -0.61 | -1.54 | -0.39 | 0.54 | -0.37 |
2021-03-31 | -0.61 | -2.70 | -0.32 | 0.67 | -0.32 |
2020-12-31 | -0.53 | -1.75 | -0.78 | 0.33 | -0.50 |
2020-09-30 | -0.62 | -1.39 | -0.81 | 0.26 | -0.56 |
2020-06-30 | -0.36 | -0.74 | -0.84 | -0.29 | -0.79 |
Gross Margins
- marjin kotor untuk Pulmatrix, Inc. pada 2025 Jun 30 adalah 0.98.
- marjin bersih untuk Pulmatrix, Inc. pada 2025 Jun 30 adalah -6.35.
- marjin operasi untuk Pulmatrix, Inc. pada 2025 Jun 30 adalah -5.07.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | 0.98 | -6.35 | -5.07 |
2025-03-31 | 0.98 | -1.22 | -0.92 |
2024-12-31 | -0.07 | -0.97 | -0.74 |
2024-09-30 | -0.21 | -0.95 | -0.99 |
2024-06-30 | -0.63 | -0.76 | -0.81 |
2024-03-31 | -1.42 | -2.39 | -2.48 |
2023-12-31 | -1.42 | -2.39 | -2.48 |
2023-09-30 | -1.57 | -2.53 | -2.60 |
2023-06-30 | -1.80 | -2.53 | -2.60 |
2023-03-31 | 1.00 | -2.86 | -2.90 |
2022-12-31 | 0.72 | -3.87 | -3.87 |
2022-09-30 | 0.98 | -3.87 | -3.87 |
2022-06-30 | 0.94 | -5.42 | -4.53 |
2022-03-31 | 1.00 | -4.26 | -3.54 |
2021-12-31 | -1.34 | -3.90 | -3.21 |
2021-09-30 | -0.55 | -2.84 | -2.27 |
2021-06-30 | -0.55 | -2.14 | -1.19 |
2021-03-31 | -0.26 | -1.66 | -0.82 |
2020-12-31 | -0.24 | -1.53 | -0.78 |
2020-09-30 | -0.34 | -1.66 | -0.92 |
2020-06-30 | -0.71 | -1.44 | -1.46 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1574235 |
Grupong Pang-industriya
SIC 2834 - Pharmaceutical Preparations |